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Abstract
Background: Traumatic spinal cord injuries (TSCI) are a neu-
rological condition associated with reduced well-being, in-
creased morbidity and reductions in life expectancy. Esti-
mates of all-cause and cause-specific mortality can aid in 
identifying targets for prevention and management of con-
tributors for premature mortality. Objectives: To compare 
all-cause and cause-specific rates of mortality to that of the 
Swiss general population; to identify differentials in risk of 
cause-specific mortality according to lesion characteristics. 
Methods: All-cause and cause-specific standardized mortal-
ity ratios (SMRs) were calculated using data from the Swiss 
Spinal Cord Injury cohort study. Cause-specific subhazard ra-
tios were estimated within a competing risk framework us-
ing flexible parametric survival models. Results: Between 
1990 and 2011, 2,492 persons sustained a TSCI, of which 379 
died. Persons with TSCI had a mortality rate more than 
2 times higher than that of the Swiss general population 
(SMR 2.32; 95% CI 2.10–2.56). Tetraplegic lesions were asso-
ciated with an increased risk of mortality due to respiratory 
and cardiovascular diseases, infections, and accidents. 
Cause-specific SMRs were notably elevated for SCI-related 
conditions such as urinary tract infections (UTIs) and septice-
mia. Conclusions: Elevated SMRs due to cardiovascular dis-
ease, UTIs and septicemia-related mortality suggest the 
need for innovation when managing associated secondary 
health conditions. © 2019 S. Karger AG, Basel
Introduction
In a recent re-evaluation of the WHO Global Burden of 
Disease study [1], neurological diseases were identified as 
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overall global aging, the number of people affected with 
neurological diseases is only expected to augment, regard-
less of notable reductions in age-standardized rates [2]. 
Traumatic spinal cord injuries (TSCIs), comprised within 
the assemblage of neurological diseases, are a disabling 
condition associated with reduced functioning and quality 
of life, increased morbidity, and reductions in life expec-
tancy. In comparison to the general population, persons 
with TSCI have a roughly 2.5 times greater risk of mortal-
ity (standardized mortality ratio [SMR] 2.5, 95% CI 1.9–
3.2) [3]. This burden of mortality is similar to what has 
been estimated for other chronic neurological conditions 
such as multiple sclerosis (SMR 2.8, 95% CI 2.7–2.9) [4] or 
traumatic brain injury (SMR 2.3; 95% CI 2.1–2.4) [5]. 
Reductions in premature mortality associated with 
neurological diseases would aid in reducing the global 
burden of disease. Unfortunately, most research on 
long-term mortality risk post-SCI has found little to no 
improvements in recent decades [3], and although per-
sons with SCI have the potential for a life expectancy 
similar to that of the general population, within-popu-
lation and between-country discrepancies in mortality 
and survival estimates exist [3, 6]. Importantly, these 
discrepancies reflect the influence of SCI characteristics 
and health systems on risk of mortality, and can thereby 
be exploited to identify targeted interventions and areas 
for innovation. To this aim, estimates of all-cause and 
cause-specific mortality can aid in identifying targets for 
prevention and management of contributors for prema-
ture mortality. Furthermore, cause-specific mortality 
comparisons to the general population can help with 
benchmarking to identify target areas for health system 
improvement. The purpose of this study is to thereby 
provide cause-specific mortality estimates within the 




The present study employs data collected in the Swiss Spinal 
Cord Injury (SwiSCI) cohort on incident cases of TSCI admitted 
to a specialized rehabilitation facility between 1990 and 2011 [7]. 
Information on cause of deaths (CoDs) was obtained through 
probabilistic linkage [8] with the Swiss National Cohort (SNC) 
based on date of birth, date of death (when available), geocoded 
address, age and sex; applying a similar methodology as that used 
in previous studies [9, 10]. New cases of SCI admitted to an ac-
tive specialized rehabilitation facility within Switzerland were el-
igible for linkage. Of the original 6,162 cases, including incident 
cases of non-traumatic and traumatic SCI from pre-1960, 85.5% 
were linked (n = 5,266) to the SNC data. A weight was created 
corresponding to the likelihood of a correct match for persons 
within the SwiSCI dataset with multiple potential matches 
(21.6%). Records with the highest weight were used in analyses, 
secondary matches – alternative links – were included in a sen-
sitivity analysis. 
Causes of Death
For each linked mortality record, up to 5 causes or contributing 
causes of death were recorded using ICD-8 (until 1994) and ICD-
10 coding (1995 and later): the underlying CoD; the initial cause 
of disease; the consecutive disease; and 2 concomitant diseases. 
Classification of cases based on ICD-8 coding were too few to war-
rant stratified analysis by ICD version or similar (n = 22). Previous 
studies using CoD information have used the underlying CoD for 
analyses, which is defined as the disease or injury that initiated 
events leading to death, including chronic conditions [11]. A hier-
archical approach was used to identify the CoD relevant for cause-
specific mortality analyses and the calculation of SMRs, as imple-
mented in previous studies [12]. This approach skips over CoDs 
related to an external injury code (e.g., sequelae from traffic acci-
dent) or SCI-related ICD code to identify a CoD relevant for sec-
ondary prevention. For example, when using this hierarchical ap-
proach, a CoD coded as “paraplegia/tetraplegia” or “external in-
jury” at the primary, secondary, or tertiary level was ignored until 
a code unrelated to SCI was identified, if available. 
A categorical variable was created to group causes of death into 
6 broad categories based on expert opinion, previous literature 
[13], data availability, as well as identifying meaningful groups for 
targeted prevention. These groups include respiratory diseases 
(ICD-10 codes = J30-J99 – excluding respiratory infections); car-
diovascular disease (I00-I99); neoplasms (C00-D49); infections 
(including respiratory and urinary tract infections (UTIs): 
 A00-B99, J00-J22, N390-392); accidents (S00-Y99, excluding 
 X60-X84); and all other causes of mortality. 
Statistical Analysis
SMRs involve the calculation of expected event rates, which are 
compared to the observed event rates. We calculated the expected 
CoD-specific mortality rates using general population CoD, age, 
sex, and calendar year-specific mortality rates obtained from the 
SNC. To do this, we partitioned the observed follow-up time of 
persons with an SCI by age, sex, and calendar year. Flexible para-
metric models within a competing-risk framework were used to 
estimate cause-specific subhazard ratios (sHRs) [14]. Separate 
baseline  hazards were estimated for circulatory and respiratory dis-
eases, as well as accidents and all other causes to allow for potential 
time-varying effects according to CoD. Attained age, lesion level, 
and completeness were assumed to have an influence on cause-
specific mortality, and were therefore interacted with each CoD to 
allow for the effect of these covariates to vary according to CoD. 
Attained age at death or study end was accomplished with data 
splitting techniques. 
Given the potential for coding inaccuracies in CoD statistics, 
2 plausible alternative coding scenarios were implemented to eval-
uate the robustness of results: 
– Sensitivity analysis 1: Re-calculation of SMRs using the origi-
nal underlying CoD, not applying hierarchical coding scheme 
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– Sensitivity analysis 2: Competing-risk analysis for pre-identi-
fied SCI-related causes of interest (i.e., respiratory infections and 
UTI/renal failure) recorded anywhere on death certificate (i.e., un-
derlying CoD, initial disease, consecutive, or concomitant; online 
suppl. Tables 2, 3).
Finally, given that it was not possible to apply the coding hier-
archy to the GP in a similarly informed hierarchical process re-
garding disease history with available data, in a secondary analysis 
only “community-dwelling cases” (defined as individuals with at 
least 1 year or more of follow-up time) were included for SMR cal-
culation according to CoD.
All analyses were carried out using Stata version 14.2 [15].
Results
Summary Statistics 
Between 1990 and 2011, 2,492 persons were admitted 
for first rehabilitation within a specialized rehabilitation 
center; of which, 379 had a known date of death, contrib-
uting to 20,099.9 years of follow-up time. CoD informa-
tion was available for 335 cases (Table 1 and online  suppl. 
Table 1). Excluding deaths due to accident- or SCI- related 
ICD-10 codes, cardiac disease (11.9%), ischemic heart 
disease (10.1%), neoplasms (8.1%), and suicide (6.3%) 
were the most commonly recorded CoDs (Table 1). 
 Accidents were less frequently recorded when excluding 
deaths that occurred <1 year post-injury  (Table 1). 
The overall mortality rate for persons with TSCI was 
more than 2 times higher than that of the Swiss GP 
(SMR 2.32; 95% CI 2.10–2.56; Table 2). SMRs were el-
evated for women (SMR 2.61; 95% CI 2.18–3.13) and 
tetraplegics (SMR 2.65; 95% CI 2.31–3.04; Table 2). The 
synergistic influence of lesion level and completeness on 
mortality rates was evidenced in that the mortality rate 
for incomplete paraplegics was 1.6 times that of the GP 
(SMR 1.64; 95% CI 1.32–2.03), while for complete tet-
raplegics, the difference was 8.5 times higher than that 
of the GP (SMR 8.49; 95% CI 6.55–11.01; Table 2).
Table 1. Causes of death stratified by total, survival 1 year post-injury, and SCI characteristics
Cause of death Total 
(n = 335)
Survival more 
than 1 year 
post-injury 
total (n = 229)
Completeness of SCI 
(missing = 17)
Level of SCI 
(missing = 1)
incomplete complete tetraplegia paraplegia
Respiratory infection (J00-J22) 19 (5.7) 13 (5.7) 13 (6.2) 6 (5.6) 4 (2.9) 15 (8.3)
Chronic obstructive pulmonary disease (J40-J47) 2 (0.6) 1 (0.4) 2 (0.9) – – 2 (1.1)
Other respiratory disease (J30-J99) 19 (5.7) 10 (4.4) 7 (3.3) 11 (10.3) 8 (5.8) 11 (6.1)
Cardiac disease (I05-I09; I11; I30-I59) 40 (11.9) 25 (10.9) 24 (11.4) 15 (14.0) 14 (10.1) 26 (14.4)
Ischemic heart disease (I20-I25) 34 (10.1) 28 (12.2) 28 (13.3) 5 (4.7) 11 (7.9) 21 (11.6)
Cerebral, circulatory disease (I60-I69) 13 (3.9) 11 (4.8) 10 (4.7) 2 (1.9) 3 (2.2) 9 (5.0)
Pulmonary, circulatory disease (I26-I28) 16 (4.8) 9 (3.9) 9 (4.3) 7 (6.5) 7 (5.0) 9 (5.0)
Other circulatory disease (I10; I12-I15; I70-I99) 19 (5.7) 12 (5.2) 11 (5.2) 7 (6.5) 12 (8.6) 7 (3.9)
Neoplasms (C00-D49) 27 (8.1) 21 (9.2) 20 (9.5) 4 (3.7) 13 (9.4) 13 (7.2)
Urinary infection (N390-N392) 7 (2.1) 7 (3.1) 4 (1.9) 3 (2.8) 4 (2.9) 3 (1.7)
Renal failure (N17-N19) 2 (0.6) – 2 (0.9) – 1 (0.7) 1 (0.6)
Digestive-related disease (K00-K95) 17 (5.1) 13 (5.7) 15 (7.1) 1 (0.9) 10 (7.2) 5 (2.8)
Suicide (X71-X83) 21 (6.3) 18 (7.9) 14 (6.6) 7 (6.5) 12 (8.6) 5 (2.8)
Accidents (S00-T88; V00-X58) 28 (8.4) 7 (3.1) 11 (5.2) 14 (13.1) 8 (5.8) 20 (11.0)
Skin-related disease (L00-L99) 1 (0.3) 1 (0.4) – 1 (0.9) 1 (0.7) –
Infectious disease (A00-B99, excl. A41) 4 (1.2) 3 (1.3) 2 (0.9) 2 (1.9) 3 (2.2) –
Septicemia (A41) 7 (2.1) 5 (2.2) 4 (1.9) 3 (2.8) 3 (2.2) 4 (2.2)
Ill-defined (R00-R99) 12 (3.6) 9 (3.9) 9 (4.3) 2 (1.9) 4 (2.9) 6 (3.3)
Nervous System-related disease (G00-G99) 19 (5.7) 16 (7.0) 9 (4.3) 9 (8.4) 10 (7.2) 9 (5.0)
Endocrine-related disease (E00-E89) 9 (2.7) 7 (3.1) 3 (1.4) 5 (4.7) 4 (2.9) 4 (2.2)
Musculoskeletal-related disease (M00-M99) 7 (2.1) 4 (1.7) 7 (3.3) – 2 (1.4) 5 (2.8)
Mental-related disease (F01-F99) 11 (3.3) 8 (3.5) 6 (2.8) 3 (2.8) 5 (3.6) 5 (2.8)
Immune, blood, eye/ear-related disease 
(D50-D89; H00-H59) 1 (0.3) 1 (0.4) 1 (0.5) – – 1 (0.6)
























































Chamberlain et al.Neuroepidemiology 2019;52:205–213208
DOI: 10.1159/000496976
Cause-Specific Mortality
Cause-specific SMRs are presented in Table 3. Relative 
to the GP, persons with TSCI experienced the highest 
burden of mortality due to septicemia-related deaths 
(SMR 19.71; 95% CI 9.40–41.35; Table 3). With the ex-
ception of a few specific causes of death (e.g., chronic 
obstructive pulmonary disease and neoplasms), mortal-
ity rates for persons with SCI were higher overall in com-
parison with the GP (Table 3). For example, persons with 
SCI experienced mortality rates due to cardiovascular 
disease 2.7 times greater than that of the general popula-
tion (SMR 2.67, 95% CI 2.23–3.19; including cardiac dis-
ease, ischemic heart disease, and all circulatory diseases). 
Cause-specific SMRs further varied according to SCI 
characteristics (Table 4). When not applying a hierarchi-
cal coding scheme, SMRs for accidents and nervous sys-
tem-related diseases augmented, while SMRs estimated 
for respiratory infections, other respiratory and other cir-
culatory diseases diminished and were no longer differ-
ent than mortality rates experienced by the GP (online 
suppl. Table 2). However, when including only individu-
als who survived at least 1-year post-injury, while cause-
specific SMRs remained relatively stable in general, the 
SMR for accident-related CoDs notably reduced in com-
parison to SMRs including all deaths (Table 3).
SHRs are presented in Table 5. Regardless of specific 
CoD, sHRs were highest for the oldest age group (60 years 
and older; Table 5). Following adjustment, tetraplegic le-
sions were associated with an increased risk of mortality 
due to respiratory and cardiovascular diseases, infections, 
and accidents (Table 5). Complete lesions were also associ-
ated with an elevated risk for mortality due to respiratory 
diseases and accidents (Table 5). With the exception of age, 
there was no difference in risk of mortality due to neo-
plasms or other causes according to lesion characteristics. 
In a separate analysis on risk of mortality due to respira-
tory infections, sHRs were elevated for both for tetraplegic 
and complete lesions (online suppl. Table 3). This relation-
ship remained when including all individuals with a respi-
ratory infection coded on the death certificate, regardless 
of the position (online suppl. Table 3). No differential in 
risk of mortality due to UTI/renal failure was identified ac-
cording to lesion characteristics (online suppl Table 4). 
Discussion
Persons with a TSCI have a more than doubled rate of 
mortality in comparison with the GP, with augmenting 
disparities associated with increasing severity. Further-
more, cause-specific SMRs as well as risk for cause-spe-
cific mortality varied according to lesion level and com-
pleteness, with tetraplegic and complete lesions exhibit-
ing a higher risk in mortality due to respiratory and 
cardiovascular disease, infections, and accidents in com-
parison with paraplegic and incomplete lesions. 
Table 2. All-cause SMRs
Number of deaths Expected deaths SMR (95% CI)
Overall 376 162.19 2.32 (2.10–2.56)
Gender
Male 257 116.63 2.20 (1.95–2.49)
Female 119 45.56 2.61 (2.18–3.13)
Lesion level*
Paraplegia 156 76.71 2.03 (1.74–2.38)
Tetraplegia 203 76.55 2.65 (2.31–3.04)
Completeness*
Incomplete 218 116.15 1.88 (1.64–2.14)
Complete 125 32.42 3.86 (3.24–4.60)
Level and completeness*
Incomplete paraplegia 83 50.64 1.64 (1.32–2.03)
Complete paraplegia 68 25.52 2.66 (2.10–3.38)
Incomplete tetraplegia 135 65.53 2.06 (1.74–2.44)
Complete tetraplegia 57 6.71 8.49 (6.55–11.01)
* Excluding cauda equina lesions.
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Cardiovascular diseases, suicide, and systemic infec-
tions are the leading causes of death in the present study 
population when excluding accident and nervous system-
related ICD codes. In comparison with previous studies, 
some discrepancies in leading causes of death can be not-
ed; for example, Savic et al. [13] reported respiratory dis-
eases (including infections), circulatory diseases and neo-
plasms as the leading causes of mortality for individuals 
who survived at least 1 year post-injury. Additionally, in 
terms of direction and magnitude of the effect, differenc-
es exist between country-level comparisons of cause-spe-
cific SMRs. For example, in the United States, DeVivo et 
al. [16] reported a higher rate of cancer-related mortality 
among the SCI population compared to the GP, and re-
ported SMRs nearly half that of what was estimated in this 
study for suicide. In contrast, 2 studies from Estonia and 
Norway estimated similarly heighted suicide-specific 
SMRs compared with the present study [17, 18]. Such dif-
ferences could be impacted by incomplete and poorly in-
formed coding practices of death certificates [19]. Age- 
and sex-specific mortality stratified by ICD-10 coding 
groups for the European standardized population could 
help improve comparability between countries, and 
thereby aid in benchmarking across health systems for 
chronic disease populations. 
Mortality rates between 2- and 3-times that of the GP 
have been regularly reported in recent SCI literature [3]. 
Unfortunately, despite advances in medical technology 
and rehabilitation, a multitude of studies have found only 
limited or no improvement in long-term mortality [20, 
21]. The cause-specific SMR estimates reported in this 
study help identify potential causes that may be driving 
the overall mortality differential. For example, not only 
was cardiovascular disease the leading CoD, but also per-
sons with SCI were found to have about a 2.5 times great-
er risk of mortality due to cardiovascular disease in com-
parison with the GP. Modifications in cardiovascular dis-
ease risk post-SCI are likely related to physiologic changes 
associated with lesion level and severity. For example, im-
mediately following SCI, the autonomic nervous system 
incurs physiological alterations that have both acute and 
chronic implications on cardiovascular functioning, such 
Table 3. Cause-specific SMRs, overall and 1 year post-injury




SMR (95% CI) Survived at least 1 year post-injury
number of deaths SMR (95% CI)
Respiratory infection 19 3.12 6.10 (3.89–9.56) 13 4.29 (2.49–7.38)
Chronic obstructive pulmonary disease 2 3.71 0.54 (0.13–2.16) 1 0.28 (0.04–1.95)
Other respiratory disease 19 5.04 3.77 (2.41–5.91) 10 2.02 (1.09–3.75)
Cardiac disease 40 10.62 3.77 (2.76–5.13) 25 2.41 (1.63–3.56)
Ischemic heart disease 34 18.27 1.86 (1.33–2.60) 28 1.56 (1.08–2.27)
Cerebral, circulatory disease 13 8.37 1.55 (0.90–2.67) 11 1.34 (0.74–2.42)
Pulmonary, circulatory disease 16 0.88 18.15 (11.12–29.63) 9 10.38 (5.40–19.95)
Other circulatory disease 19 7.21 2.50 (1.57–3.96) 12 1.70 (0.96–2.99)
Neoplasms 27 38.37 0.70 (0.48–1.03) 21 0.56 (0.36–0.85)
Urinary infection 7 0.39 18.16 (8.66–38.10) 7 18.54 (8.84–38.90)
Renal failure 2 0.65 3.06 (0.77–12.25) 0 –
Digestive disease 17 5.11 3.32 (2.07–5.35) 13 2.59 (1.50–4.45)
Suicide 21 3.16 6.65 (4.34–10.20) 18 5.76 (3.63–9.14)
Accidents 28 5.02 5.57 (3.85–8.07) 7 1.42 (0.67–2.97)
Skin-related disease 1 0.17 5.88 (0.83–41.77) 1 6.00 (0.84–42.57)
Infectious disease 4 1.54 2.59 (0.97–6.91) 3 1.97 (0.64–6.12)
Septicemia 7 0.36 19.71 (9.40–41.35) 5 14.35 (5.97–34.46)
Ill-defined 12 4.49 2.68 (1.52–4.71) 9 2.04 (1.06–3.92)
Nervous system-related disease 19 5.77 3.29 (2.10–5.16) 16 2.82 (1.73–4.61)
Endocrine-related disease 9 3.66 2.46 (1.28–4.72) 7 1.95 (0.93–4.08)
Musculoskeletal-related disease 7 1.02 6.88 (3.28–14.43) 4 4.01 (1.50–10.67)
Mental-related disease 11 6.28 1.75 (0.97–3.16) 8 1.30 (0.65–2.60)
Immune, blood, eye/ear-related disease 1 0.35 2.85 (0.40–20.27) 1 2.91 (0.41–20.65)
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as unstable blood pressure, autonomic dysreflexia (AD) 
and orthostatic hypotension, associated with a multitude 
of cardiovascular complications, including cardiac arrest, 
intracranial hemorrhage, stroke, and death [22]. Reflect-
ing the influence of lesion characteristics on the risk of 
cardiovascular disease, AD – a response to stimuli below 
the lesion level characterized by an acute elevation of the 
systolic blood pressure – has been estimated to be 3-times 
more common in individuals with complete tetraplegic 
lesions in comparison to individuals with incomplete le-
sions, with AD occurring primarily in high thoracic (para-
plegic) and cervical (tetraplegic) lesions [22]. However, 
although pharmaceutical interventions and guidelines are 
available for the management of AD, persons with SCI are 
still estimated to experience an average of 11 AD episodes 
per day [22], with episodes continuing to occur many 
years post-SCI [23]. The persistence of AD episodes as 
well as UTIs or pneumonia despite following the guide-
lines of best clinical practice and management, suggest the 
need for innovation in post-SCI care to improve long-
term mortality outcomes [24]. 
Strengths and Limitations
This study uses information from a large, nationally 
representative cohort of persons admitted for first reha-
bilitation within a specialized SCI center in Switzerland; 
therefore, study results are generalizable to other high-in-
come rehabilitation settings. It is important to note that 
despite complete coverage of specialized rehabilitation, 
there is evidence to suggest that not all individuals who 
attain a TSCI in Switzerland attend specialized rehabilita-
tion; therefore, results are not generalizable to all persons 
in Switzerland who have a traumatic SCI [25]. However, 
some limitations exist. For example, many CoDs had 
small case numbers, thereby requiring caution when 
drawing conclusions from absolute numbers. Addition-
ally, previous research has found that the CoD informa-
tion coded on death certificates lacks reliability when 
identifying the true underlying CoD [26, 27]. Assuming 
non-differential misclassification of codes between the GP 
and the TSCI population, for the present study, relative 
estimates of mortality would likely be attenuated towards 
the null, so over- or under-estimation of mortality differ-
Table 4. Cause-specific SMRs stratified by lesion characteristics








Respiratory infection 2.98 (1.12–7.94) 9.23 (5.57–15.32) 5.21 (3.03–8.98) 12.35 (5.55–27.50)
Chronic obstructive pulmonary disease – 1.06 (0.27–4.24) 0.66 (0.17–2.65) –
Other respiratory disease 3.58 (1.79–7.15) 4.33 (2.40–7.82) 1.71 (0.82–3.59) 14.12 (7.82–25.50)
Cardiac disease 2.97 (1.76–5.02) 4.85 (3.30–7.13) 2.84 (1.90–4.24) 8.73 (5.26–14.48)
Ischemic heart disease 1.35 (0.75–2.44) 2.30 (1.50–3.52) 1.91 (1.32–2.77) 1.72 (0.72–4.13)
Cerebral, circulatory disease 0.81 (0.26–2.52) 2.12 (1.10–4.07) 1.50 (0.81–2.79) 1.47 (0.37–5.87)
Pulmonary, circulatory disease 17.01 (8.11–35.68) 21.35 (11.11–41.03) 13.15 (6.84–25.26) 42.59 (20.30–89.34)
Other circulatory disease 3.44 (1.90–6.20) 1.93 (0.92–4.05) 1.73 (0.93–3.21) 6.15 (2.93–12.91)
Neoplasms 0.70 (0.41–1.21) 0.74 (0.43–1.28) 0.68 (0.44–1.05) 0.53 (0.20–1.40)
Urinary infection 23.73 (8.90–63.21) 15.17 (4.89–47.03) 12.74 (4.78–33.95) 52.54 (16.94–162.89)
Renal failure 3.42 (0.48–24.27) 3.07 (0.43–21.77) 3.76 (0.94–15.05) –
Digestive disease 4.12 (2.22–7.65) 2.11 (0.88–5.06) 3.79 (2.28–6.28) 1.05 (0.15–7.42)
Suicide 6.82 (3.87–12.01) 4.42 (1.84–10.61) 6.63 (3.92–11.19) 7.87 (3.75–16.50)
Accidents 3.16 (1.58–6.31) 9.37 (6.04–14.52) 3.01 (1.67–5.43) 12.48 (7.39–21.07)
Skin-related disease 12.93 (1.82–91.76) – – 34.50 (4.86–244.88)
Infectious disease 3.90 (1.26–12.09) – 1.76 (0.44–7.03) 5.89 (1.47–23.54)
Septicemia 18.54 (5.98–57.47) 23.04 (8.65–61.38) 14.20 (5.33–37.83) 50.09 (16.16–155.31)
Ill-defined 1.86 (0.70–4.96) 2.92 (1.31–6.50) 2.61 (1.36–5.02) 2.31 (0.58–9.24)
Nervous system-related disease 3.79 (2.04–7.04) 3.20 (1.66–6.15) 1.97 (1.03–3.79) 9.07 (4.72–17.42)
Endocrine-related disease 2.36 (0.89–6.29) 2.27 (0.85–6.04) 1.05 (0.34–3.25) 7.65 (3.18–18.37)
Musculoskeletal-related disease 4.30 (1.08–17.20) 10.04 (4.18–24.11) 8.78 (4.19–18.41) –
Mental-related disease 1.74 (0.73–4.19) 1.64 (0.68–3.94) 1.21 (0.54–2.69) 2.81 (0.91–8.72)
Immune, blood, eye/ear-related disease – 5.96 (0.84–42.28) 3.68 (0.52–26.09) –
SMRs not calculated for those CoDs with insufficient cases.














































































Table 5. Competing risk analysis of risk factors for cause-specific mortality, sHRs
Respiratory diseases (n = 21) Cardiovascular diseases (n = 122) Neoplasms (n = 27)
univariable multivariable univariable multivariable univariable multivariable
Age at injury
<46 years Ref. Ref. Ref. Ref. Ref. Ref.
46–60 years 6.59 (0.74–58.96) 5.07 (0.53–48.83) 2.63 (1.09–6.33) 2.48 (1.02–5.99) 5.67 (1.18–27.29) 3.56 (0.69–18.38)
≥60 years 28.94 (3.84–218.26) 27.71 (3.62–212.31) 22.34 (10.86–45.94) 16.43 (7.87–34.31) 15.71 (3.63–68.01) 9.91 (2.24–43.78)
Lesion level
Paraplegia Ref. Ref. Ref. Ref. Ref. Ref.
Tetraplegia 2.60 (1.08–6.28) 3.37 (1.29–8.80) 2.58 (1.79–3.73) 2.22 (1.50–3.30) 1.68 (0.78–3.63) 1.45 (0.62–3.37)
Completeness
Incomplete Ref. Ref. Ref. Ref. Ref. Ref.
Complete 2.25 (0.93–5.42) 4.95 (1.97–12.46) 0.78 (0.52–1.15) 1.50 (0.99–2.28) 0.36 (0.12–1.06) 0.55 (0.18–1.66)
Infections (n = 37) Accidents (n = 28) Other (n = 100)
univariable multivariable univariable multivariable univariable multivariable
Age at injury  
<46 years Ref. Ref. Ref. Ref. Ref. Ref.
46–60 years 0.69 (0.18–2.68) 0.67 (0.17–2.59) 1.43 (0.48–4.25) 1.38 (0.42–4.53) 1.44 (0.73–2.82) 1.16 (0.58–2.34)
≥60 years 6.87 (2.98–15.82) 5.53 (2.34–13.07) 3.74 (1.52–9.18) 3.57 (1.33–9.60) 5.75 (3.38–9.78) 4.31 (2.48–7.49)
Lesion level
Paraplegia Ref. Ref. Ref. Ref. Ref. Ref.
Tetraplegia 2.65 (1.35–5.17) 2.65 (1.32–5.34) 3.79 (1.67–8.60) 3.93 (1.65–9.37) 1.41 (0.93–2.14) 1.30 (0.83–2.02)
Completeness
Incomplete Ref. Ref. Ref. Ref. Ref. Ref.
Complete 1.09 (0.56–2.13) 1.96 (0.96–4.00) 2.40 (1.09–5.30) 4.25 (1.86–9.72) 0.82 (0.52–1.29) 1.15 (0.72–1.84)
The group “Respiratory diseases” excludes respiratory infections, while the group “Infections” includes respiratory infections, septicemia, urinary tract infections, 
and all other infections. Sex and cause of TSCI were included in the analyses as potential confounders.
sHR, subhazard ratio.
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entials is unlikely. Another potential limitation of the cur-
rent study was the use of probabilistic linkage to collect 
information on CoDs, and the resulting potential for in-
correct linkages. However, a sensitivity analysis using sec-
ondary alternative links found no meaningful influence 
on study results that would modify interpretation (online 
suppl. Table 5). Although unlinked deaths would bias ab-
solute mortality rates, this study investigates relative mor-
tality, for which unlinked deaths have been shown to have 
limited impact [28]. Finally, important targets for primary 
interventions include secondary health conditions – such 
as bladder control, pain, or pressure ulcers – which are 
notably missing from the present study. Currently, this in-
formation coupled with mortality outcomes is not avail-
able within the context of the Swiss SCI population. 
Conclusion
The particularly elevated cause-specific SMRs reported 
within this study for cardiovascular diseases, UTIs, and sep-
ticemia-related mortality require innovative approaches for 
management of SCI-associated secondary health condi-
tions, as well as targeted interventions for known risk factors. 
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